"O Hospital de Messejana Dr. Carlos Alberto Studart Gomes (HM) é uma unidade pública, da Secretaria de Saúde do Ceará (Sesa), especializada no diagnóstico e tratamento de doenças cardíacas e pulmonares."

During the past decade, Hospital de Messejana dr. Carlos Alberto Studart Gomes conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hospital Israelita Albert Einstein" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "EMS" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hospital Sirio-Libanes" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are "Acute Coronary Syndrome" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Coronavirus Infections" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" in a lesser frequency.

Most popular intervention types in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Antiplatelet Monotherapy" (1 trials), "Hydroxychloroquine" (1 trials) and "Hydroxychloroquine + azithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Messejana dr. Carlos Alberto Studart Gomes". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital de Messejana dr. Carlos Alberto Studart Gomes, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Messejana dr. Carlos Alberto Studart Gomes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".